Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Global prostate cancer disparities and the parts both genetic and behavioural factors play

Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville, USA
Global prostate cancer disparities and the parts both genetic and behavioural factors play ( Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville, USA )
28 Aug 2014

New players and targets in tumour vasculature

Dr Ugo Cavallaro - European Institue of Oncology, Milan, Italy
New players and targets in tumour vasculature ( Dr Ugo Cavallaro - European Institue of Oncology, Milan, Italy )
27 Aug 2014

ecancermedicalscience editor's choice for July and August 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for July and August 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Aug 2014

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion

Prof Aristoteles Giagounidis; Dr Francesco Zaja; Dr James Bussel; Dr Howard Liebman
Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion ( Prof Aristoteles Giagounidis; Dr Francesco Zaja; Dr James Bussel; Dr Howard Liebman )
13 Aug 2014

Melanoma live: Making patient-focused therapy decisions

Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long
Melanoma live: Making patient-focused therapy decisions ( Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long )
1 Aug 2014

Quality of life and cost advantages of metronomics and drug repurposing

Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK
Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )
10 Jul 2014

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic
Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies ( Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic )
10 Jul 2014

Industry view of targeted therapy combinations in oncology

Dr Susan Galbraith – AstraZeneca, Macclesfield, UK
Industry view of targeted therapy combinations in oncology ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )
26 Jun 2014

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA
Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Jun 2014

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA
WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )
26 Jun 2014

Work of the WIN consortium and challenges of personalised cancer therapy

Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, USA
Work of the WIN consortium and challenges of personalised cancer therapy ( Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Jun 2014

Combining immunological and targeted agents in melanoma

Dr Axel Hoos - GlaxoSmithKline, Collegeville, USA
Combining immunological and targeted agents in melanoma ( Dr Axel Hoos - GlaxoSmithKline, Collegeville, USA )
26 Jun 2014